Thomas W. Dubensky

Filings by Thomas W. Dubensky span 2 companies, the busiest being Chinook Therapeutics, Inc. and Tempest Therapeutics, Inc. The record holds 69 filings, for trades running from 16 November 2015 to 7 January 2022.

Both buying and selling appear: 1 purchase worth €8,463, against 32 sales worth €6.7M. Taken together, the sales exceed the purchases by €6.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 34 option exercises. So far in 2022, the count stands at 1 purchase and no sales.

The record was last updated on 11 January 2022 with an open-market purchase (€8,463) in Tempest Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.